These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 18162609)

  • 21. [Signaling mechanism involved in regulation of endothelial cell-cell junctions].
    Fukuhara S; Mochizuki N
    Yakugaku Zasshi; 2010 Nov; 130(11):1413-20. PubMed ID: 21048397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player.
    Vestweber D; Winderlich M; Cagna G; Nottebaum AF
    Trends Cell Biol; 2009 Jan; 19(1):8-15. PubMed ID: 19010680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VE-cadherin at a glance.
    Bravi L; Dejana E; Lampugnani MG
    Cell Tissue Res; 2014 Mar; 355(3):515-22. PubMed ID: 24643676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation.
    Duong CN; Nottebaum AF; Butz S; Volkery S; Zeuschner D; Stehling M; Vestweber D
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):378-393. PubMed ID: 31826650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions.
    Chrifi I; Louzao-Martinez L; Brandt MM; van Dijk CGM; Bürgisser PE; Zhu C; Kros JM; Verhaar MC; Duncker DJ; Cheng C
    Angiogenesis; 2019 Feb; 22(1):75-93. PubMed ID: 30097810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VE-cadherin: at the front, center, and sides of endothelial cell organization and function.
    Harris ES; Nelson WJ
    Curr Opin Cell Biol; 2010 Oct; 22(5):651-8. PubMed ID: 20708398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions.
    Del Maschio A; Zanetti A; Corada M; Rival Y; Ruco L; Lampugnani MG; Dejana E
    J Cell Biol; 1996 Oct; 135(2):497-510. PubMed ID: 8896605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular-endothelial-cadherin modulates endothelial monolayer permeability.
    Hordijk PL; Anthony E; Mul FP; Rientsma R; Oomen LC; Roos D
    J Cell Sci; 1999 Jun; 112 ( Pt 12)():1915-23. PubMed ID: 10341210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of artificial and natural VE-cadherin-based adherens junctions.
    Taveau JC; Dubois M; Le Bihan O; Trépout S; Almagro S; Hewat E; Durmort C; Heyraud S; Gulino-Debrac D; Lambert O
    Biochem Soc Trans; 2008 Apr; 36(Pt 2):189-93. PubMed ID: 18363560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial-cadherin and vascular stability.
    Dejana E; Giampietro C
    Curr Opin Hematol; 2012 May; 19(3):218-23. PubMed ID: 22395663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Vascular Endothelial Growth Factor (VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch.
    Tian Y; Gawlak G; O'Donnell JJ; Birukova AA; Birukov KG
    J Biol Chem; 2016 May; 291(19):10032-45. PubMed ID: 26884340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VE-PTP stabilizes VE-cadherin junctions and the endothelial barrier via a phosphatase-independent mechanism.
    Juettner VV; Kruse K; Dan A; Vu VH; Khan Y; Le J; Leckband D; Komarova Y; Malik AB
    J Cell Biol; 2019 May; 218(5):1725-1742. PubMed ID: 30948425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced endothelial barrier function by monoclonal antibody activation of vascular endothelial cadherin.
    Park KS; Schecterson L; Gumbiner BM
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1403-H1410. PubMed ID: 33577432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels.
    Bach TL; Barsigian C; Chalupowicz DG; Busler D; Yaen CH; Grant DS; Martinez J
    Exp Cell Res; 1998 Feb; 238(2):324-34. PubMed ID: 9473340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cadherins and tumor angiogenesis.
    Cavallaro U; Liebner S; Dejana E
    Exp Cell Res; 2006 Mar; 312(5):659-67. PubMed ID: 16256984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin.
    Ham C; Levkau B; Raines EW; Herren B
    Exp Cell Res; 2002 Oct; 279(2):239-47. PubMed ID: 12243749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial permeability and VE-cadherin: a wacky comradeship.
    Gavard J
    Cell Adh Migr; 2014; 8(2):158-64. PubMed ID: 25422846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial (VE)-cadherin: only an intercellular glue?
    Dejana E; Bazzoni G; Lampugnani MG
    Exp Cell Res; 1999 Oct; 252(1):13-9. PubMed ID: 10502395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of endothelial barrier function during normal angiogenesis requires homotypic VE-cadherin adhesion.
    DeFouw LM; DeFouw DO
    Tissue Cell; 2000 Jun; 32(3):238-42. PubMed ID: 11037794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VE-cadherin complex plasticity: EPS8 and YAP play relay at adherens junctions.
    Giampietro C
    Tissue Barriers; 2016; 4(4):e1232024. PubMed ID: 28123926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.